“These totals affirm that targeting unregulated marijuana-related growing operations still remains a DEA priority.”
Region: DC
The newly proposed rules expand the DEA’s authority by declaring it to be the only entity legally permitted to purchase, warehouse, and dispense any cannabis grown under a federal license.
The FDA is “actively evaluating potential rulemaking to allow CBD in dietary supplements.”
Senators urge “the Subcommittee on Financial Services and General Government to include language in … forthcoming legislation to help extend SBA loan programs to legal cannabis businesses.”
Survey data compiled by YouGov.com reported that 53 percent of respondents believe that medical marijuana dispensaries “should be considered essential services.”
These new rules are unduly onerous, expensive, and impractical. It is unlikely that they would greatly facilitate clinical cannabis research in the United States.
With numerous states designating medical cannabis facilities as ‘essential’ during this time of crisis, it is critical that the Small Business Association to similarly recognize their importance.
To date, the agency has approved plans submitted by the following states: Delaware, Georgia, Louisiana, Montana, Nebraska, New Jersey, Ohio, Texas, Washington, and Wyoming.